A cluster-randomized trial to reduce major perinatal morbidity among women with one prior cesarean delivery in Québec (PRISMA trial): study protocol for a randomized controlled trial.
A cluster-randomized trial to reduce major perinatal morbidity among women with one prior cesarean delivery in Québec (PRISMA trial): study protocol for a randomized controlled trial.
复制标题
DOI:
10.1186/s13063-017-2150-x
复制
发表时间:
2017-09-20
期刊:
影响因子:
2.5
通讯作者:
PRISMA Trial Research Group
中科院分区:
文献类型:
--
作者:
Chaillet N;Bujold E;Masse B;Grobman WA;Rozenberg P;Pasquier JC;Shorten A;Johri M;Beaudoin F;Abenhaim H;Demers S;Fraser W;Dugas M;Blouin S;Dubé E;Gauthier R;PRISMA Trial Research Group
Rates of cesarean delivery are continuously increasing in industrialized countries, with repeated cesarean accounting for about a third of all cesareans. Women who have undergone a first cesarean are facing a difficult choice for their next pregnancy, i.e.: (1) to plan for a second cesarean delivery, associated with higher risk of maternal complications than vaginal delivery; or (b) to have a trial of labor (TOL) with the aim to achieve a vaginal birth after cesarean (VBAC) and to accept a significant, but rare, risk of uterine rupture and its related maternal and neonatal complications. The objective of this trial is to assess whether a multifaceted intervention would reduce the rate of major perinatal morbidity among women with one prior cesarean. The study is a stratified, non-blinded, cluster-randomized, parallel-group trial of a multifaceted intervention. Hospitals in Quebec are the units of randomization and women are the units of analysis. As depicted in Figure 1, the study includes a 1-year pre-intervention period (baseline), a 5-month implementation period, and a 2-year intervention period. At the end of the baseline period, 20 hospitals will be allocated to the intervention group and 20 to the control group, using a randomization stratified by level of care. Medical records will be used to collect data before and during the intervention period. Primary outcome is the rate of a composite of major perinatal morbidities measured during the intervention period. Secondary outcomes include major and minor maternal morbidity; minor perinatal morbidity; and TOL and VBAC rate. The effect of the intervention will be assessed using the multivariable generalized-estimating-equations extension of logistic regression. The evaluation will include subgroup analyses for preterm and term birth, and a cost-effectiveness analysis. The intervention is designed to facilitate: (1) women’s decision-making process, using a decision analysis tool (DAT), (2) an estimate of uterine rupture risk during TOL using ultrasound evaluation of low-uterine segment thickness, (3) an estimate of chance of TOL success, using a validated prediction tool, and (4) the implementation of best practices for intrapartum management. Current Controlled Trials, ID: ISRCTN15346559. Registered on 20 August 2015. The online version of this article (doi:10.1186/s13063-017-2150-x) contains supplementary material, which is available to authorized users.
登录
查看更多内容
影响因子:
168.9
作者:
Dumont, Alexandre;Fournier, Pierre;Fraser, William D.
通讯作者:
Fraser, William D.
DOI:
10.1016/s1701-2163(16)34478-4
发表时间:
2010-04-01
影响因子:
1.8
作者:
Bujold, Emmanuel;Jastrow, Nicole;Chaillet, Nils
通讯作者:
Chaillet, Nils
影响因子:
7.2
作者:
Costantine, Maged M.;Fox, Karin;Saade, George
通讯作者:
Saade, George
影响因子:
3.6
作者:
Briggs, Andrew H.;Weinstein, Milton C.;Paltiel, A. David
通讯作者:
Paltiel, A. David
影响因子:
9.8
作者:
Bergeron, Marie-Eve;Beaudet, Christine;Laberge, Philippe
通讯作者:
Laberge, Philippe